MtF transgender patient with a pathogenic BRCA2 mutation. We also review the available literature on related issues, as well as the pathogenesis of breast cancer in specific circumstances. Case report A 46-year-old biologically male patient
Search Results
Vinciane Corman, Iulia Potorac, Florence Manto, Sarah Dassy, Karin Segers, Albert Thiry, Vincent Bours, Adrian F Daly, and Albert Beckers
Neil A Bhowmick, Jillian Oft, Tanya Dorff, Sumanta Pal, Neeraj Agarwal, Robert A Figlin, Edwin M Posadas, Stephen J Freedland, and Jun Gong
absence of a change in estradiol significantly increased renal ACE2 mRNA expression in rats compared to control ( Dasinger et al . 2016 ). In an analysis of RNA-sequencing/microarray datasets, transgender males who underwent androgen targeted therapy for
